Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects (Multiple Sclerosis and Related Disorders, 2012)

(untitled) - Bibani, R; Tench, C; George, J; Manouchehrinia, A; Palace, J; Constantinescu, C